Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on July 6, 2026

Jul. 6, 2026

Ozeina Appoints Dr. Akler as Medical Director to Lead Clinical Excellence and Advance Its Longevity Care Platform

Indeterminate EIN Presswire

Jul. 6, 2026

Homely MD Appoints Dr. Akler as Medical Director to Strengthen Its Healthcare Platform

Indeterminate EIN Presswire

Jul. 6, 2026

A Culture of Care: Working Nurses Homecare Named a 2026 Top Workplace

Indeterminate EIN Presswire

Jul. 6, 2026

Deutsche Dental Technologien Showcases KERA Ceramic Burs and Root Tip Extraction Forceps at 2026 FAP/FPA Joint Meeting

Indeterminate EIN Presswire

Jul. 6, 2026

Miami GEO Pro Partners with Jordanne Sculler, LMHC to Optimize Practice for AI Search

Indeterminate EIN Presswire

Jul. 6, 2026

As FDA Eases Hormone Therapy Warnings, Orlando's Aspire Rejuvenation Marks Six Years Ahead of the Curve

Indeterminate EIN Presswire

Jul. 6, 2026

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Bilan semestriel du Contrat de Liquidité de DBV Technologies avec ODDO BHF

Indeterminate GlobeNewswire

Jul. 6, 2026

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs

Indeterminate GlobeNewswire

Jul. 6, 2026

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

Indeterminate GlobeNewswire

Jul. 6, 2026

Vireo Growth Inc. Engages Independent Trading Group (ITG), Inc. as Market Maker

Indeterminate GlobeNewswire

Jul. 6, 2026

Context Therapeutics Added to Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax Announces Closing of $920 Million Public Offering

Indeterminate GlobeNewswire

Jul. 6, 2026

Abivax annonce la réalisation de son offre au public de 920 millions de dollars

Indeterminate GlobeNewswire

Jul. 6, 2026

Longeveron® Appoints Marie Washburn as Chief Financial Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 6, 2026

Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis

Indeterminate GlobeNewswire

Jul. 6, 2026

Aligos Therapeutics Receives Upfront Payment of $25M USD from the Exclusive License Deal of Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection

Indeterminate GlobeNewswire

Jul. 6, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire